Interleukin-17A Contributes to Myocardial Ischemia/Reperfusion Injury by Regulating Cardiomyocyte Apoptosis and Neutrophil Infiltration

This study tested whether interleukin (IL)-17A is involved in the pathogenesis of mouse myocardial ischemia/reperfusion (I/R) injury and investigated the mechanisms. Inflammatory processes play a major role in myocardial I/R injury. We recently identified IL-17A as an important cytokine in inflammat...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 59; no. 4; pp. 420 - 429
Main Authors Liao, Yu-Hua, Xia, Ni, Zhou, Su-Feng, Tang, Ting-Ting, Yan, Xin-Xin, Lv, Bing-Jie, Nie, Shao-Fang, Wang, Jing, Iwakura, Yoichiro, Xiao, Hong, Yuan, Jing, Jevallee, Harish, Wei, Fen, Shi, Guo-Ping, Cheng, Xiang
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 24.01.2012
Elsevier
Elsevier Limited
Subjects
EF
IL
ELR
LV
FS
I/R
mAb
AAR
rIL
MIP
KC
LIX
EC
Online AccessGet full text

Cover

Loading…
Abstract This study tested whether interleukin (IL)-17A is involved in the pathogenesis of mouse myocardial ischemia/reperfusion (I/R) injury and investigated the mechanisms. Inflammatory processes play a major role in myocardial I/R injury. We recently identified IL-17A as an important cytokine in inflammatory cardiovascular diseases such as atherosclerosis and viral myocarditis. However, its role in myocardial I/R injury remains unknown. The involvement of IL-17A was assessed in functional assays in mouse myocardial I/R injury by neutralization/repletion or genetic deficiency of IL-17A, and its mechanism on cardiomyocyte apoptosis and neutrophil infiltration were further studied in vivo and in vitro. Interleukin-17A was elevated after murine left coronary artery ligation and reperfusion. Intracellular cytokine staining revealed that γδT lymphocytes but not CD4+ helper T cells were a major source of IL-17A. Anti–IL-17A monoclonal antibody treatment or IL-17A knockout markedly ameliorated I/R injury, as demonstrated by reduced infarct size, reduced cardiac troponin T levels, and improved cardiac function. This improvement was associated with a reduction in cardiomyocyte apoptosis and neutrophil infiltration. In contrast, repletion of exogenous IL-17A induced the opposite effect. In vitro study showed that IL-17A mediated cardiomyocyte apoptosis through regulating the Bax/Bcl-2 ratio, induced CXC chemokine-mediated neutrophil migration and promoted neutrophil-endothelial cell adherence through induction of endothelial cell E-selectin and inter-cellular adhesion molecule-1 expression. IL-17A mainly produced by γδT cells plays a pathogenic role in myocardial I/R injury by inducing cardiomyocyte apoptosis and neutrophil infiltration.
AbstractList This study tested whether interleukin (IL)-17A is involved in the pathogenesis of mouse myocardial ischemia/reperfusion (I/R) injury and investigated the mechanisms.OBJECTIVESThis study tested whether interleukin (IL)-17A is involved in the pathogenesis of mouse myocardial ischemia/reperfusion (I/R) injury and investigated the mechanisms.Inflammatory processes play a major role in myocardial I/R injury. We recently identified IL-17A as an important cytokine in inflammatory cardiovascular diseases such as atherosclerosis and viral myocarditis. However, its role in myocardial I/R injury remains unknown.BACKGROUNDInflammatory processes play a major role in myocardial I/R injury. We recently identified IL-17A as an important cytokine in inflammatory cardiovascular diseases such as atherosclerosis and viral myocarditis. However, its role in myocardial I/R injury remains unknown.The involvement of IL-17A was assessed in functional assays in mouse myocardial I/R injury by neutralization/repletion or genetic deficiency of IL-17A, and its mechanism on cardiomyocyte apoptosis and neutrophil infiltration were further studied in vivo and in vitro.METHODSThe involvement of IL-17A was assessed in functional assays in mouse myocardial I/R injury by neutralization/repletion or genetic deficiency of IL-17A, and its mechanism on cardiomyocyte apoptosis and neutrophil infiltration were further studied in vivo and in vitro.Interleukin-17A was elevated after murine left coronary artery ligation and reperfusion. Intracellular cytokine staining revealed that γδT lymphocytes but not CD4(+) helper T cells were a major source of IL-17A. Anti-IL-17A monoclonal antibody treatment or IL-17A knockout markedly ameliorated I/R injury, as demonstrated by reduced infarct size, reduced cardiac troponin T levels, and improved cardiac function. This improvement was associated with a reduction in cardiomyocyte apoptosis and neutrophil infiltration. In contrast, repletion of exogenous IL-17A induced the opposite effect. In vitro study showed that IL-17A mediated cardiomyocyte apoptosis through regulating the Bax/Bcl-2 ratio, induced CXC chemokine-mediated neutrophil migration and promoted neutrophil-endothelial cell adherence through induction of endothelial cell E-selectin and inter-cellular adhesion molecule-1 expression.RESULTSInterleukin-17A was elevated after murine left coronary artery ligation and reperfusion. Intracellular cytokine staining revealed that γδT lymphocytes but not CD4(+) helper T cells were a major source of IL-17A. Anti-IL-17A monoclonal antibody treatment or IL-17A knockout markedly ameliorated I/R injury, as demonstrated by reduced infarct size, reduced cardiac troponin T levels, and improved cardiac function. This improvement was associated with a reduction in cardiomyocyte apoptosis and neutrophil infiltration. In contrast, repletion of exogenous IL-17A induced the opposite effect. In vitro study showed that IL-17A mediated cardiomyocyte apoptosis through regulating the Bax/Bcl-2 ratio, induced CXC chemokine-mediated neutrophil migration and promoted neutrophil-endothelial cell adherence through induction of endothelial cell E-selectin and inter-cellular adhesion molecule-1 expression.IL-17A mainly produced by γδT cells plays a pathogenic role in myocardial I/R injury by inducing cardiomyocyte apoptosis and neutrophil infiltration.CONCLUSIONSIL-17A mainly produced by γδT cells plays a pathogenic role in myocardial I/R injury by inducing cardiomyocyte apoptosis and neutrophil infiltration.
This study tested whether interleukin (IL)-17A is involved in the pathogenesis of mouse myocardial ischemia/reperfusion (I/R) injury and investigated the mechanisms. Inflammatory processes play a major role in myocardial I/R injury. We recently identified IL-17A as an important cytokine in inflammatory cardiovascular diseases such as atherosclerosis and viral myocarditis. However, its role in myocardial I/R injury remains unknown. The involvement of IL-17A was assessed in functional assays in mouse myocardial I/R injury by neutralization/repletion or genetic deficiency of IL-17A, and its mechanism on cardiomyocyte apoptosis and neutrophil infiltration were further studied in vivo and in vitro. Interleukin-17A was elevated after murine left coronary artery ligation and reperfusion. Intracellular cytokine staining revealed that γδT lymphocytes but not CD4(+) helper T cells were a major source of IL-17A. Anti-IL-17A monoclonal antibody treatment or IL-17A knockout markedly ameliorated I/R injury, as demonstrated by reduced infarct size, reduced cardiac troponin T levels, and improved cardiac function. This improvement was associated with a reduction in cardiomyocyte apoptosis and neutrophil infiltration. In contrast, repletion of exogenous IL-17A induced the opposite effect. In vitro study showed that IL-17A mediated cardiomyocyte apoptosis through regulating the Bax/Bcl-2 ratio, induced CXC chemokine-mediated neutrophil migration and promoted neutrophil-endothelial cell adherence through induction of endothelial cell E-selectin and inter-cellular adhesion molecule-1 expression. IL-17A mainly produced by γδT cells plays a pathogenic role in myocardial I/R injury by inducing cardiomyocyte apoptosis and neutrophil infiltration.
Objectives This study tested whether interleukin (IL)-17A is involved in the pathogenesis of mouse myocardial ischemia/reperfusion (I/R) injury and investigated the mechanisms. Background Inflammatory processes play a major role in myocardial I/R injury. We recently identified IL-17A as an important cytokine in inflammatory cardiovascular diseases such as atherosclerosis and viral myocarditis. However, its role in myocardial I/R injury remains unknown. Methods The involvement of IL-17A was assessed in functional assays in mouse myocardial I/R injury by neutralization/repletion or genetic deficiency of IL-17A, and its mechanism on cardiomyocyte apoptosis and neutrophil infiltration were further studied in vivo and in vitro. Results Interleukin-17A was elevated after murine left coronary artery ligation and reperfusion. Intracellular cytokine staining revealed that γδT lymphocytes but not CD4+helper T cells were a major source of IL-17A. Anti-IL-17A monoclonal antibody treatment or IL-17A knockout markedly ameliorated I/R injury, as demonstrated by reduced infarct size, reduced cardiac troponin T levels, and improved cardiac function. This improvement was associated with a reduction in cardiomyocyte apoptosis and neutrophil infiltration. In contrast, repletion of exogenous IL-17A induced the opposite effect. In vitro study showed that IL-17A mediated cardiomyocyte apoptosis through regulating the Bax/Bcl-2 ratio, induced CXC chemokine-mediated neutrophil migration and promoted neutrophil-endothelial cell adherence through induction of endothelial cell E-selectin and inter-cellular adhesion molecule-1 expression. Conclusions IL-17A mainly produced by γδT cells plays a pathogenic role in myocardial I/R injury by inducing cardiomyocyte apoptosis and neutrophil infiltration.
OBJECTIVES: This study tested whether interleukin (IL)-17A is involved in the pathogenesis of mouse myocardial ischemia/reperfusion (I/R) injury and investigated the mechanisms. BACKGROUND: Inflammatory processes play a major role in myocardial I/R injury. We recently identified IL-17A as an important cytokine in inflammatory cardiovascular diseases such as atherosclerosis and viral myocarditis. However, its role in myocardial I/R injury remains unknown. METHODS: The involvement of IL-17A was assessed in functional assays in mouse myocardial I/R injury by neutralization/repletion or genetic deficiency of IL-17A, and its mechanism on cardiomyocyte apoptosis and neutrophil infiltration were further studied in vivo and in vitro. RESULTS: Interleukin-17A was elevated after murine left coronary artery ligation and reperfusion. Intracellular cytokine staining revealed that gamma delta T lymphocytes but not CD4+ helper T cells were a major source of IL-17A. Anti-IL-17A monoclonal antibody treatment or IL-17A knockout markedly ameliorated I/R injury, as demonstrated by reduced infarct size, reduced cardiac troponin T levels, and improved cardiac function. This improvement was associated with a reduction in cardiomyocyte apoptosis and neutrophil infiltration. In contrast, repletion of exogenous IL-17A induced the opposite effect. In vitro study showed that IL-17A mediated cardiomyocyte apoptosis through regulating the Bax/Bcl-2 ratio, induced CXC chemokine-mediated neutrophil migration and promoted neutrophil-endothelial cell adherence through induction of endothelial cell E-selectin and inter-cellular adhesion molecule-1 expression. CONCLUSIONS: IL-17A mainly produced by gamma delta T cells plays a pathogenic role in myocardial I/R injury by inducing cardiomyocyte apoptosis and neutrophil infiltration.
ObjectivesThis study tested whether interleukin (IL)-17A is involved in the pathogenesis of mouse myocardial ischemia/reperfusion (I/R) injury and investigated the mechanisms. BackgroundInflammatory processes play a major role in myocardial I/R injury. We recently identified IL-17A as an important cytokine in inflammatory cardiovascular diseases such as atherosclerosis and viral myocarditis. However, its role in myocardial I/R injury remains unknown. MethodsThe involvement of IL-17A was assessed in functional assays in mouse myocardial I/R injury by neutralization/repletion or genetic deficiency of IL-17A, and its mechanism on cardiomyocyte apoptosis and neutrophil infiltration were further studied in vivo and in vitro. ResultsInterleukin-17A was elevated after murine left coronary artery ligation and reperfusion. Intracellular cytokine staining revealed that γδT lymphocytes but not CD4 + helper T cells were a major source of IL-17A. Anti–IL-17A monoclonal antibody treatment or IL-17A knockout markedly ameliorated I/R injury, as demonstrated by reduced infarct size, reduced cardiac troponin T levels, and improved cardiac function. This improvement was associated with a reduction in cardiomyocyte apoptosis and neutrophil infiltration. In contrast, repletion of exogenous IL-17A induced the opposite effect. In vitro study showed that IL-17A mediated cardiomyocyte apoptosis through regulating the Bax/Bcl-2 ratio, induced CXC chemokine-mediated neutrophil migration and promoted neutrophil-endothelial cell adherence through induction of endothelial cell E-selectin and inter-cellular adhesion molecule-1 expression. ConclusionsIL-17A mainly produced by γδT cells plays a pathogenic role in myocardial I/R injury by inducing cardiomyocyte apoptosis and neutrophil infiltration.
Author Xia, Ni
Xiao, Hong
Wei, Fen
Yan, Xin-Xin
Liao, Yu-Hua
Cheng, Xiang
Wang, Jing
Nie, Shao-Fang
Lv, Bing-Jie
Shi, Guo-Ping
Jevallee, Harish
Iwakura, Yoichiro
Yuan, Jing
Zhou, Su-Feng
Tang, Ting-Ting
Author_xml – sequence: 1
  givenname: Yu-Hua
  surname: Liao
  fullname: Liao, Yu-Hua
  organization: Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
– sequence: 2
  givenname: Ni
  surname: Xia
  fullname: Xia, Ni
  organization: Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
– sequence: 3
  givenname: Su-Feng
  surname: Zhou
  fullname: Zhou, Su-Feng
  organization: Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
– sequence: 4
  givenname: Ting-Ting
  surname: Tang
  fullname: Tang, Ting-Ting
  organization: Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
– sequence: 5
  givenname: Xin-Xin
  surname: Yan
  fullname: Yan, Xin-Xin
  organization: Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
– sequence: 6
  givenname: Bing-Jie
  surname: Lv
  fullname: Lv, Bing-Jie
  organization: Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
– sequence: 7
  givenname: Shao-Fang
  surname: Nie
  fullname: Nie, Shao-Fang
  organization: Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
– sequence: 8
  givenname: Jing
  surname: Wang
  fullname: Wang, Jing
  organization: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
– sequence: 9
  givenname: Yoichiro
  surname: Iwakura
  fullname: Iwakura, Yoichiro
  organization: Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo, Japan
– sequence: 10
  givenname: Hong
  surname: Xiao
  fullname: Xiao, Hong
  organization: First Hospital of Wuhan, Wuhan, China
– sequence: 11
  givenname: Jing
  surname: Yuan
  fullname: Yuan, Jing
  organization: Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
– sequence: 12
  givenname: Harish
  surname: Jevallee
  fullname: Jevallee, Harish
  organization: Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
– sequence: 13
  givenname: Fen
  surname: Wei
  fullname: Wei, Fen
  organization: Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
– sequence: 14
  givenname: Guo-Ping
  surname: Shi
  fullname: Shi, Guo-Ping
  email: gshi@rics.bwh.harvard.edu
  organization: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
– sequence: 15
  givenname: Xiang
  surname: Cheng
  fullname: Cheng, Xiang
  email: nathancx@mail.hust.edu.cn
  organization: Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25665784$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22261166$$D View this record in MEDLINE/PubMed
BookMark eNqFkl2L1DAUhousuLOrf8ALKYjoTWdz-pGmiwjD4MfAqrDqdUjT0910O0lNUqG_wL9t6owuDDheBcLzvOHkvGfRiTYao-gpkCUQoBfdshNSLlMCEC6WjGYPogUUBUuyoipPogUpsyIBUpWn0ZlzHSGEMqgeRadpmlIAShfRz432aHsc75ROoFzFa6O9VfXo0cXexB8nI4VtlOjjjZO3uFXi4hoHtO3olNHxRnejneJ6iq_xZuyFV_omXs-G2QZ18hivBjN445SLhW7iTzh6a4ZbFQJ1q3pvg2P04-hhK3qHT_bnefTt3duv6w_J1ef3m_XqKpEUmE_arC5oXsqqKrOaoCBQspzUkGUVzRsgNINc5nVeyLIVKOuqFRIqbFhZZU1Tkew8ernLHaz5PqLzfKucxL4XGs3oeAUlFGUJEMhXR0kghLGUsnQOfX6Adma0OszBgeYFybOMzoHP9tRYb7Hhg1VbYSf-ZxkBeLEHhJOib63QUrl7rqC0COMGLt1x0hrnLLZ_ESB8bgbv-NwMPjdjvgvNCBI7kKTyv78-bED1x9XXOxXDYn4otNxJhVpioyxKzxujjutvDnTZK63ChHc4obv_Ku5STviXubVzaQFIzoClIeDy3wH_e_0XleX8Lw
CODEN JACCDI
CitedBy_id crossref_primary_10_1152_ajprenal_00242_2016
crossref_primary_10_1016_j_humgen_2022_201089
crossref_primary_10_3389_fcvm_2022_968752
crossref_primary_10_3389_fimmu_2021_732794
crossref_primary_10_1155_2014_573745
crossref_primary_10_1007_s11655_018_2976_4
crossref_primary_10_1016_j_bbamcr_2020_118798
crossref_primary_10_1016_j_biopha_2025_117898
crossref_primary_10_1080_13813455_2021_1912102
crossref_primary_10_1111_jcmm_16441
crossref_primary_10_1590_1414_431x20209717
crossref_primary_10_1016_j_lfs_2020_117329
crossref_primary_10_1007_s00018_022_04307_0
crossref_primary_10_1016_j_matbio_2020_04_001
crossref_primary_10_1111_tri_12197
crossref_primary_10_1016_j_autrev_2017_07_009
crossref_primary_10_1016_j_imbio_2022_152220
crossref_primary_10_1089_dna_2013_2003
crossref_primary_10_1371_journal_pone_0072059
crossref_primary_10_1016_j_bcp_2023_115975
crossref_primary_10_1093_jleuko_qiac012
crossref_primary_10_1007_s12265_012_9410_7
crossref_primary_10_3390_ijms24076497
crossref_primary_10_1161_CIRCRESAHA_116_308030
crossref_primary_10_2174_1570159X21666230308090351
crossref_primary_10_1016_j_ijcard_2017_01_102
crossref_primary_10_1016_j_intimp_2013_11_008
crossref_primary_10_3390_stresses4020016
crossref_primary_10_1155_2021_6454177
crossref_primary_10_1152_ajpheart_00250_2023
crossref_primary_10_3390_cells12040605
crossref_primary_10_1111_jcmm_16335
crossref_primary_10_1016_j_yjmcc_2018_01_001
crossref_primary_10_3390_jcdd9020063
crossref_primary_10_1155_2021_6415275
crossref_primary_10_1002_jcp_24941
crossref_primary_10_1186_s13020_022_00616_5
crossref_primary_10_1007_s10495_016_1258_x
crossref_primary_10_1016_j_molimm_2019_01_008
crossref_primary_10_1007_s11010_023_04822_z
crossref_primary_10_1016_j_brainres_2017_08_023
crossref_primary_10_1016_j_cophys_2020_09_002
crossref_primary_10_1016_j_obmed_2019_100098
crossref_primary_10_1007_s10753_019_01002_4
crossref_primary_10_3892_ijmm_2015_2204
crossref_primary_10_1016_j_cbi_2019_01_032
crossref_primary_10_2174_1874372201812010070
crossref_primary_10_1038_s44161_022_00067_z
crossref_primary_10_1007_s10753_013_9771_3
crossref_primary_10_1038_nri3800
crossref_primary_10_3390_ijms22042036
crossref_primary_10_1007_s00011_017_1060_4
crossref_primary_10_1016_j_cellsig_2020_109690
crossref_primary_10_3389_fphar_2021_651150
crossref_primary_10_1111_cei_12284
crossref_primary_10_1038_s41598_023_30666_0
crossref_primary_10_1161_CIRCRESAHA_116_304794
crossref_primary_10_1155_2016_8160393
crossref_primary_10_1042_BSR20170899
crossref_primary_10_1111_jce_12850
crossref_primary_10_1177_1074248419869618
crossref_primary_10_1016_j_jaad_2018_02_040
crossref_primary_10_1007_s11739_020_02422_z
crossref_primary_10_1186_s13613_016_0157_1
crossref_primary_10_1038_s41584_019_0243_5
crossref_primary_10_3389_fnmol_2017_00271
crossref_primary_10_1371_journal_pone_0092216
crossref_primary_10_1002_JLB_3MA0520_716R
crossref_primary_10_1111_sji_12245
crossref_primary_10_3892_ijmm_2017_3008
crossref_primary_10_1161_JAHA_122_027228
crossref_primary_10_1093_eurheartj_ehae205
crossref_primary_10_1161_JAHA_123_032533
crossref_primary_10_1371_journal_pone_0144877
crossref_primary_10_1093_cvr_cvab161
crossref_primary_10_1097_CP9_0000000000000008
crossref_primary_10_1016_j_yjmcc_2023_11_008
crossref_primary_10_3390_biom13091382
crossref_primary_10_1096_fj_201900060R
crossref_primary_10_4070_kcj_2016_46_6_753
crossref_primary_10_1093_cvr_cvu039
crossref_primary_10_1371_journal_pone_0070236
crossref_primary_10_1097_MOT_0000000000000064
crossref_primary_10_1007_s11033_021_06326_9
crossref_primary_10_1038_srep04774
crossref_primary_10_1016_j_biomaterials_2013_09_010
crossref_primary_10_2147_CCID_S392165
crossref_primary_10_1038_s41374_019_0320_z
crossref_primary_10_15212_CVIA_2016_0067
crossref_primary_10_1038_s41401_021_00659_8
crossref_primary_10_1007_s11886_017_0896_0
crossref_primary_10_1016_j_cyto_2015_06_016
crossref_primary_10_1002_iid3_1220
crossref_primary_10_1016_j_ijcard_2015_06_152
crossref_primary_10_1016_j_ijcard_2014_04_021
crossref_primary_10_1016_j_intimp_2023_110962
crossref_primary_10_1016_j_brainres_2014_07_002
crossref_primary_10_3390_ijms24129888
crossref_primary_10_1089_ars_2016_6940
crossref_primary_10_1038_srep42678
crossref_primary_10_1161_HYPERTENSIONAHA_113_02604
crossref_primary_10_1002_ctm2_301
crossref_primary_10_1016_j_phrs_2021_105606
crossref_primary_10_1016_j_amjms_2024_08_001
crossref_primary_10_1080_14779072_2022_2132230
crossref_primary_10_1016_j_atherosclerosis_2025_119119
crossref_primary_10_1007_s00109_014_1176_8
crossref_primary_10_1160_TH12_05_0341
crossref_primary_10_1016_j_jep_2024_117902
crossref_primary_10_3892_mmr_2017_7771
crossref_primary_10_1097_BOR_0b013e3283620036
crossref_primary_10_1016_j_yjmcc_2012_10_002
crossref_primary_10_3389_fcell_2022_672391
crossref_primary_10_1007_s13258_023_01475_6
crossref_primary_10_1016_j_molimm_2018_12_014
crossref_primary_10_1007_s00011_014_0765_x
crossref_primary_10_1016_j_bbamcr_2016_08_013
crossref_primary_10_3389_fcvm_2022_951670
crossref_primary_10_1089_ther_2016_0042
crossref_primary_10_1631_jzus_BQICC701
crossref_primary_10_1002_jcb_28816
crossref_primary_10_1016_j_gene_2013_05_041
crossref_primary_10_1371_journal_pone_0132654
crossref_primary_10_1371_journal_pone_0094551
crossref_primary_10_3389_fimmu_2016_00409
crossref_primary_10_1016_j_jcmgh_2017_12_012
crossref_primary_10_1038_s44161_024_00471_7
crossref_primary_10_1097_MCA_0000000000000997
crossref_primary_10_1161_JAHA_116_004406
crossref_primary_10_1016_j_actbio_2021_01_025
crossref_primary_10_1016_j_jss_2015_05_060
crossref_primary_10_4049_jimmunol_1700655
crossref_primary_10_1016_j_ijcard_2014_03_086
crossref_primary_10_3892_mmr_2019_10568
crossref_primary_10_1021_jm400014c
crossref_primary_10_3389_fphys_2020_529075
crossref_primary_10_3109_14017431_2012_699096
crossref_primary_10_1007_s00395_024_01036_2
crossref_primary_10_1097_FJC_0000000000000711
crossref_primary_10_3892_mmr_2017_6963
crossref_primary_10_1161_JAHA_112_004408
crossref_primary_10_12659_MSM_898015
crossref_primary_10_1161_CIRCULATIONAHA_114_008788
crossref_primary_10_1016_j_ejphar_2020_173092
crossref_primary_10_1111_ijd_13420
crossref_primary_10_1038_s41420_024_02064_6
crossref_primary_10_1038_srep26543
crossref_primary_10_1161_CIRCRESAHA_116_304072
crossref_primary_10_1038_srep33636
crossref_primary_10_1111_sji_12298
crossref_primary_10_1111_nyas_12134
crossref_primary_10_1111_tri_12349
crossref_primary_10_3389_fphys_2021_695047
crossref_primary_10_1038_s41420_023_01792_5
crossref_primary_10_1016_j_freeradbiomed_2013_02_012
crossref_primary_10_1016_j_ejphar_2014_11_012
crossref_primary_10_1155_2020_3908641
crossref_primary_10_1155_2019_5164298
crossref_primary_10_1016_j_regen_2019_100016
crossref_primary_10_1038_s41598_017_07573_2
crossref_primary_10_3892_mmr_2018_9037
crossref_primary_10_4049_jimmunol_1202975
crossref_primary_10_3390_ijms21145013
crossref_primary_10_1111_jcmm_15178
crossref_primary_10_1111_jcmm_16389
crossref_primary_10_1042_CS20140672
crossref_primary_10_1111_bph_13781
crossref_primary_10_1042_CS20190682
crossref_primary_10_1007_s12012_024_09921_x
crossref_primary_10_3389_fnins_2022_1032434
crossref_primary_10_3892_mmr_2017_7839
crossref_primary_10_3389_fimmu_2018_00399
crossref_primary_10_1093_eurheartj_ehs263
crossref_primary_10_1160_TH13_03_0211
crossref_primary_10_1016_j_nefro_2020_11_009
crossref_primary_10_1371_journal_pone_0188202
crossref_primary_10_1007_s00395_016_0537_6
crossref_primary_10_1016_j_ejphar_2017_07_003
crossref_primary_10_1016_j_biopha_2022_113082
crossref_primary_10_1007_s00392_013_0656_0
crossref_primary_10_1161_HYPERTENSIONAHA_121_18219
crossref_primary_10_1007_s11010_024_05112_y
crossref_primary_10_3390_pharmaceutics14050936
crossref_primary_10_3892_etm_2015_2880
crossref_primary_10_1152_ajpheart_00566_2019
crossref_primary_10_1038_cddis_2017_227
crossref_primary_10_1016_j_neubiorev_2013_06_010
crossref_primary_10_1007_s12265_012_9404_5
crossref_primary_10_1016_j_autrev_2019_102429
crossref_primary_10_1186_s12974_022_02414_0
crossref_primary_10_3389_fphar_2021_706617
crossref_primary_10_3389_fphar_2021_727838
crossref_primary_10_1016_j_yjmcc_2022_11_009
crossref_primary_10_3390_antiox8110546
crossref_primary_10_1002_JLB_3MR0822_761RR
crossref_primary_10_1016_j_jep_2020_112794
crossref_primary_10_1136_annrheumdis_2012_201887
crossref_primary_10_1038_s41440_018_0185_3
crossref_primary_10_3389_fimmu_2021_674542
crossref_primary_10_1016_j_intimp_2018_02_006
crossref_primary_10_1536_ihj_21_856
crossref_primary_10_3389_fendo_2020_00280
crossref_primary_10_3892_ijmm_2018_3886
crossref_primary_10_1007_s12013_020_00928_z
crossref_primary_10_1161_ATVBAHA_114_303567
crossref_primary_10_1093_ejcts_ezw367
crossref_primary_10_3389_fcvm_2023_1219316
crossref_primary_10_1016_j_ejphar_2016_06_038
crossref_primary_10_1016_j_jphs_2015_07_023
crossref_primary_10_3390_ijms21197390
crossref_primary_10_1002_ehf2_15238
crossref_primary_10_1186_s12967_018_1567_7
crossref_primary_10_1007_s11033_017_4098_z
crossref_primary_10_1016_j_bbrc_2021_03_061
crossref_primary_10_1161_CIRCULATIONAHA_118_036044
crossref_primary_10_1038_s41419_022_04533_1
crossref_primary_10_1016_j_jss_2016_02_029
crossref_primary_10_1089_jir_2019_0069
crossref_primary_10_1097_FJC_0000000000001466
crossref_primary_10_1016_j_neuroscience_2014_06_001
crossref_primary_10_1161_JAHA_119_012575
crossref_primary_10_1016_j_transproceed_2013_02_126
crossref_primary_10_1016_j_tox_2018_05_012
crossref_primary_10_1016_j_cellimm_2015_05_007
crossref_primary_10_3390_jcm12051751
crossref_primary_10_1084_jem_20132126
crossref_primary_10_1016_j_abb_2020_108720
crossref_primary_10_1097_TP_0b013e318293b7e1
crossref_primary_10_21518_ms2023_158
crossref_primary_10_3389_fimmu_2021_758272
crossref_primary_10_1124_molpharm_121_000394
crossref_primary_10_3389_fphar_2020_593633
crossref_primary_10_1016_S1995_7645_14_60186_3
crossref_primary_10_1016_j_phrs_2020_104846
crossref_primary_10_3390_ijms25021082
crossref_primary_10_1016_j_nefroe_2021_06_003
crossref_primary_10_1016_j_actbio_2022_02_018
crossref_primary_10_1007_s00395_013_0357_x
crossref_primary_10_1111_tri_12683
Cites_doi 10.1016/S0006-291X(03)00496-0
10.1189/jlb.0204065
10.1160/TH08-12-0837
10.1016/j.micinf.2009.04.003
10.1038/nature07036
10.4049/jimmunol.0901767
10.4049/jimmunol.180.1.655
10.1084/jem.20092054
10.1161/01.CIR.103.18.2296
10.1161/HYPERTENSIONAHA.109.145094
10.1056/NEJMra071667
10.4049/jimmunol.0901126
10.1016/j.cyto.2009.09.007
10.1016/j.immuni.2009.08.004
10.1152/ajpheart.2000.279.5.H2196
10.1016/j.clim.2008.09.019
10.1160/TH07-01-0022
10.4049/jimmunol.1001718
10.1016/j.clim.2008.01.009
10.1073/pnas.202474099
10.1016/j.immuni.2004.08.018
10.1016/j.coi.2008.03.006
10.1172/JCI38702
10.1385/IR:34:3:229
10.1161/01.RES.75.3.426
10.4049/jimmunol.0903162
10.1111/j.1365-2567.2009.03240.x
10.1056/NEJMe068251
10.1016/j.cardiores.2003.10.011
10.1161/CIRCRESAHA.109.213157
10.1016/S0008-6363(99)00393-4
10.1016/j.trre.2008.08.003
10.1016/j.atherosclerosis.2010.12.034
10.1038/nm.1999
10.1007/s10557-006-0583-7
10.1189/jlb.0904490
10.1128/IAI.00403-09
ContentType Journal Article
Copyright 2012 American College of Cardiology Foundation
American College of Cardiology Foundation
2015 INIST-CNRS
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Copyright Elsevier Limited Jan 24, 2012
Copyright_xml – notice: 2012 American College of Cardiology Foundation
– notice: American College of Cardiology Foundation
– notice: 2015 INIST-CNRS
– notice: Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
– notice: Copyright Elsevier Limited Jan 24, 2012
DBID 6I.
AAFTH
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
H94
K9.
NAPCQ
7X8
DOI 10.1016/j.jacc.2011.10.863
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Neurosciences Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


AIDS and Cancer Research Abstracts
AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1558-3597
EndPage 429
ExternalDocumentID 3556608751
22261166
25665784
10_1016_j_jacc_2011_10_863
S0735109711048182
1_s2_0_S0735109711048182
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: National Institutes of Health
  grantid: HL60942; HL81090; HL88547
– fundername: National Basic Research Program of China
– fundername: National Natural Science Foundation of China
  grantid: 81170303; 30871067
– fundername: NHLBI NIH HHS
  grantid: R01 HL081090
– fundername: NHLBI NIH HHS
  grantid: HL81090
– fundername: NHLBI NIH HHS
  grantid: HL88547
– fundername: NHLBI NIH HHS
  grantid: R01 HL088547
– fundername: NHLBI NIH HHS
  grantid: HL60942
– fundername: NHLBI NIH HHS
  grantid: R01 HL060942
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
18M
1B1
1P~
1~.
1~5
2WC
4.4
457
4G.
53G
5GY
5RE
5VS
6PF
7-5
71M
8P~
AABNK
AABVL
AAEDT
AAEDW
AAIKJ
AAOAW
AAQFI
AAXUO
ABBQC
ABFNM
ABFRF
ABLJU
ABMAC
ABOCM
ABWVN
ABXDB
ACGFO
ACGFS
ACIUM
ACJTP
ACPRK
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEFWE
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFPUW
AFRAH
AFRHN
AFTJW
AGCQF
AGHFR
AGYEJ
AHMBA
AIGII
AITUG
AJRQY
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BLXMC
CS3
DIK
DU5
E3Z
EBS
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FNPLU
G-Q
GBLVA
GX1
H13
HVGLF
HZ~
IHE
IXB
J1W
K-O
KQ8
L7B
MO0
N9A
O-L
O9-
OA.
OAUVE
OK1
OL~
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SSZ
TR2
UNMZH
UV1
W8F
WH7
WOQ
WOW
YYM
YZZ
Z5R
.55
.GJ
0SF
1CY
29L
3O-
3V.
6I.
7RV
AACTN
AAFTH
AAKUH
AALRI
AAQQT
AAQXK
AAYOK
ABMZM
ABVKL
AFCTW
AFETI
AFFNX
AJOXV
AMFUW
ASPBG
AVWKF
AZFZN
BENPR
BPHCQ
FGOYB
HX~
J5H
N4W
NCXOZ
QTD
R2-
RIG
SEW
T5K
X7M
XPP
YYP
ZGI
ZXP
AAIAV
ABJNI
EFLBG
LCYCR
NAHTW
ZA5
AAYWO
AAYXX
AGQPQ
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
H94
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c618t-f3b5647c9973b0ea017840b133964d106314c4b45c7faecb9fac19ed8793dd903
IEDL.DBID .~1
ISSN 0735-1097
1558-3597
IngestDate Thu Jul 10 17:22:57 EDT 2025
Fri Jul 11 06:32:14 EDT 2025
Sat Jul 26 03:01:55 EDT 2025
Mon Jul 21 06:06:20 EDT 2025
Mon Jul 21 09:15:05 EDT 2025
Tue Jul 01 03:41:20 EDT 2025
Thu Apr 24 23:02:35 EDT 2025
Fri Feb 23 02:28:21 EST 2024
Sun Feb 23 10:18:44 EST 2025
Tue Aug 26 16:32:44 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords EF
IL
ICAM
ELR
LV
mRNA
H2O2
FS
I/R
mAb
ischemia/reperfusion
LVEDP
interleukin-17
AAR
γδTCR
TUNEL
rIL
inflammation
MIP
KC
cTnT
LIX
γδT cell
EC
cardiac troponin T
ejection fraction
area at risk
γδT cell receptor-positive
messenger ribonucleic acid
left ventricle/ventricular
interleukin
terminal deoxynucleotidyl-transferase mediated dUTP nick-end labeling
lipopolysaccharide-induced CXC chemokine
endothelial cell
hydrogen peroxide
cytokine-induced neutrophil chemoattractant
recombinant interleukin
ischemia-reperfusion
left ventricular end-diastolic pressure
inter-cellular adhesion molecule
H 2O 2
macrophage inflammatory protein
glutamic acid–leucine-arginine
monoclonal antibody
fractional shortening
Heart
Interleukin
Granulocyte
Cardiovascular disease
Myocardial ischemia
Coronary heart disease
Myocardial disease
Myocyte
Vascular disease
Reperfusion
Infiltration
Circulatory system
Neutrophil
Cardiology
Apoptosis
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c618t-f3b5647c9973b0ea017840b133964d106314c4b45c7faecb9fac19ed8793dd903
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0735109711048182
PMID 22261166
PQID 1645043361
PQPubID 2031078
PageCount 10
ParticipantIDs proquest_miscellaneous_917157711
proquest_miscellaneous_1008826820
proquest_journals_1645043361
pubmed_primary_22261166
pascalfrancis_primary_25665784
crossref_primary_10_1016_j_jacc_2011_10_863
crossref_citationtrail_10_1016_j_jacc_2011_10_863
elsevier_sciencedirect_doi_10_1016_j_jacc_2011_10_863
elsevier_clinicalkeyesjournals_1_s2_0_S0735109711048182
elsevier_clinicalkey_doi_10_1016_j_jacc_2011_10_863
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-01-24
PublicationDateYYYYMMDD 2012-01-24
PublicationDate_xml – month: 01
  year: 2012
  text: 2012-01-24
  day: 24
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
– name: New York
PublicationTitle Journal of the American College of Cardiology
PublicationTitleAlternate J Am Coll Cardiol
PublicationYear 2012
Publisher Elsevier Inc
Elsevier
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier
– name: Elsevier Limited
References Zhou, Chen, Moore, Kolls, Halperin, Wang (bib34) 2009; 77
Bettelli, Korn, Oukka, Kuchroo (bib18) 2008; 453
Cheng, Taleb, Wang (bib7) 2011; 215
Kubasiak, Hernandez, Bishopric, Webster (bib30) 2002; 99
Ley, Smith, Stark (bib5) 2006; 34
Roussel, Houle, Chan (bib37) 2010; 184
Kapsenberg (bib24) 2009; 31
Miossec (bib6) 2009; 11
Shichita, Sugiyama, Ooboshi (bib13) 2009; 15
Frangogiannis (bib31) 2007; 97
Yellon, Hausenloy (bib2) 2007; 357
Zrioual, Toh, Tournadre (bib32) 2008; 180
Li, Huang, Vergis (bib14) 2010; 120
Tanaka, Ito, Adachi (bib29) 1994; 75
Nakamura, Wang, Zhao (bib25) 2000; 45
Edgerton, Crispin, Moratz (bib15) 2009; 130
Pennino, Eyerich, Scarponi (bib27) 2010; 184
Chandrasekar, Colston, de la Rosa, Rao, Freeman (bib17) 2003; 303
Vinten-Johansen (bib20) 2004; 61
Steffens, Montecucco, Mach (bib21) 2009; 102
Kolls, Linden (bib3) 2004; 21
Hamacher-Brady, Brady, Gottlieb (bib16) 2006; 20
Onishi, Gaffen (bib19) 2010; 129
Hillis, Lange (bib1) 2006; 355
Shen, Ruddy, Plamondon, Gaffen (bib28) 2005; 77
Jones, Trocha, Strange (bib36) 2000; 279
Linfert, Chowdhry, Rabb (bib22) 2009; 23
Baldeviano, Barin, Talor (bib12) 2010; 106
Yuan, Yu, Lin (bib11) 2010; 185
Ruddy, Shen, Smith, Sharma, Gaffen (bib33) 2004; 76
Xie, Wang, Tang (bib8) 2010; 49
Sonnenberg, Nair, Kirn, Zaph, Fouser, Artis (bib26) 2010; 207
Roark, Simonian, Fontenot, Born, O'Brien (bib4) 2008; 20
Erbel, Chen, Bea (bib9) 2009; 183
Cheng, Yu, Ding (bib23) 2008; 127
Madhur, Lob, McCann (bib10) 2010; 55
Chandrasekar, Smith, Freeman (bib35) 2001; 103
Linfert (10.1016/j.jacc.2011.10.863_bib22) 2009; 23
Miossec (10.1016/j.jacc.2011.10.863_bib6) 2009; 11
Kolls (10.1016/j.jacc.2011.10.863_bib3) 2004; 21
Yellon (10.1016/j.jacc.2011.10.863_bib2) 2007; 357
Bettelli (10.1016/j.jacc.2011.10.863_bib18) 2008; 453
Kapsenberg (10.1016/j.jacc.2011.10.863_bib24) 2009; 31
Zrioual (10.1016/j.jacc.2011.10.863_bib32) 2008; 180
Yuan (10.1016/j.jacc.2011.10.863_bib11) 2010; 185
Ley (10.1016/j.jacc.2011.10.863_bib5) 2006; 34
Xie (10.1016/j.jacc.2011.10.863_bib8) 2010; 49
Onishi (10.1016/j.jacc.2011.10.863_bib19) 2010; 129
Cheng (10.1016/j.jacc.2011.10.863_bib23) 2008; 127
Frangogiannis (10.1016/j.jacc.2011.10.863_bib31) 2007; 97
Edgerton (10.1016/j.jacc.2011.10.863_bib15) 2009; 130
Shen (10.1016/j.jacc.2011.10.863_bib28) 2005; 77
Zhou (10.1016/j.jacc.2011.10.863_bib34) 2009; 77
Roussel (10.1016/j.jacc.2011.10.863_bib37) 2010; 184
Nakamura (10.1016/j.jacc.2011.10.863_bib25) 2000; 45
Madhur (10.1016/j.jacc.2011.10.863_bib10) 2010; 55
Sonnenberg (10.1016/j.jacc.2011.10.863_bib26) 2010; 207
Chandrasekar (10.1016/j.jacc.2011.10.863_bib17) 2003; 303
Pennino (10.1016/j.jacc.2011.10.863_bib27) 2010; 184
Ruddy (10.1016/j.jacc.2011.10.863_bib33) 2004; 76
Chandrasekar (10.1016/j.jacc.2011.10.863_bib35) 2001; 103
Vinten-Johansen (10.1016/j.jacc.2011.10.863_bib20) 2004; 61
Kubasiak (10.1016/j.jacc.2011.10.863_bib30) 2002; 99
Roark (10.1016/j.jacc.2011.10.863_bib4) 2008; 20
Tanaka (10.1016/j.jacc.2011.10.863_bib29) 1994; 75
Erbel (10.1016/j.jacc.2011.10.863_bib9) 2009; 183
Steffens (10.1016/j.jacc.2011.10.863_bib21) 2009; 102
Jones (10.1016/j.jacc.2011.10.863_bib36) 2000; 279
Hillis (10.1016/j.jacc.2011.10.863_bib1) 2006; 355
Shichita (10.1016/j.jacc.2011.10.863_bib13) 2009; 15
Cheng (10.1016/j.jacc.2011.10.863_bib7) 2011; 215
Baldeviano (10.1016/j.jacc.2011.10.863_bib12) 2010; 106
Hamacher-Brady (10.1016/j.jacc.2011.10.863_bib16) 2006; 20
Li (10.1016/j.jacc.2011.10.863_bib14) 2010; 120
References_xml – volume: 76
  start-page: 135
  year: 2004
  end-page: 144
  ident: bib33
  article-title: Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment
  publication-title: J Leukoc Biol
– volume: 11
  start-page: 625
  year: 2009
  end-page: 630
  ident: bib6
  article-title: IL-17 and Th17 cells in human inflammatory diseases
  publication-title: Microbes Infect
– volume: 15
  start-page: 946
  year: 2009
  end-page: 950
  ident: bib13
  article-title: Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury
  publication-title: Nat Med
– volume: 129
  start-page: 311
  year: 2010
  end-page: 321
  ident: bib19
  article-title: Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
  publication-title: Immunology
– volume: 215
  start-page: 471
  year: 2011
  end-page: 474
  ident: bib7
  article-title: Inhibition of IL-17A in atherosclerosis
  publication-title: Atherosclerosis
– volume: 23
  start-page: 1
  year: 2009
  end-page: 10
  ident: bib22
  article-title: Lymphocytes and ischemia-reperfusion injury
  publication-title: Transplant Rev (Orlando)
– volume: 127
  start-page: 89
  year: 2008
  end-page: 97
  ident: bib23
  article-title: The Th17/Treg imbalance in patients with acute coronary syndrome
  publication-title: Clin Immunol
– volume: 103
  start-page: 2296
  year: 2001
  end-page: 2302
  ident: bib35
  article-title: Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine
  publication-title: Circulation
– volume: 185
  start-page: 4004
  year: 2010
  end-page: 4010
  ident: bib11
  article-title: Th17 cells contribute to viral replication in coxsackievirus B3-induced acute viral myocarditis
  publication-title: J Immunol
– volume: 355
  start-page: 2475
  year: 2006
  end-page: 2477
  ident: bib1
  article-title: Myocardial infarction and the open-artery hypothesis
  publication-title: N Engl J Med
– volume: 75
  start-page: 426
  year: 1994
  end-page: 433
  ident: bib29
  article-title: Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes
  publication-title: Circ Res
– volume: 99
  start-page: 12825
  year: 2002
  end-page: 12830
  ident: bib30
  article-title: Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3
  publication-title: Proc Natl Acad Sci U S A
– volume: 77
  start-page: 388
  year: 2005
  end-page: 399
  ident: bib28
  article-title: Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells
  publication-title: J Leukoc Biol
– volume: 183
  start-page: 8167
  year: 2009
  end-page: 8175
  ident: bib9
  article-title: Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice
  publication-title: J Immunol
– volume: 357
  start-page: 1121
  year: 2007
  end-page: 1135
  ident: bib2
  article-title: Myocardial reperfusion injury
  publication-title: N Engl J Med
– volume: 184
  start-page: 4880
  year: 2010
  end-page: 4888
  ident: bib27
  article-title: IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes
  publication-title: J Immunol
– volume: 20
  start-page: 353
  year: 2008
  end-page: 357
  ident: bib4
  article-title: gammadelta T cells: an important source of IL-17
  publication-title: Curr Opin Immunol
– volume: 303
  start-page: 1152
  year: 2003
  end-page: 1158
  ident: bib17
  article-title: TNF-alpha and H2O2 induce IL-18 and IL-18R beta expression in cardiomyocytes via NF-kappa B activation
  publication-title: Biochem Biophys Res Commun
– volume: 97
  start-page: 738
  year: 2007
  end-page: 747
  ident: bib31
  article-title: Chemokines in ischemia and reperfusion
  publication-title: Thromb Haemost
– volume: 21
  start-page: 467
  year: 2004
  end-page: 476
  ident: bib3
  article-title: Interleukin-17 family members and inflammation
  publication-title: Immunity
– volume: 102
  start-page: 240
  year: 2009
  end-page: 247
  ident: bib21
  article-title: The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury
  publication-title: Thromb Haemost
– volume: 106
  start-page: 1646
  year: 2010
  end-page: 1655
  ident: bib12
  article-title: Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy
  publication-title: Circ Res
– volume: 31
  start-page: 181
  year: 2009
  end-page: 183
  ident: bib24
  article-title: Gammadelta T cell receptors without a job
  publication-title: Immunity
– volume: 180
  start-page: 655
  year: 2008
  end-page: 663
  ident: bib32
  article-title: IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood
  publication-title: J Immunol
– volume: 55
  start-page: 500
  year: 2010
  end-page: 507
  ident: bib10
  article-title: Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction
  publication-title: Hypertension
– volume: 453
  start-page: 1051
  year: 2008
  end-page: 1057
  ident: bib18
  article-title: Induction and effector functions of T(H)17 cells
  publication-title: Nature
– volume: 207
  start-page: 1293
  year: 2010
  end-page: 1305
  ident: bib26
  article-title: Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A
  publication-title: J Exp Med
– volume: 184
  start-page: 4531
  year: 2010
  end-page: 4537
  ident: bib37
  article-title: IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation
  publication-title: J Immunol
– volume: 130
  start-page: 313
  year: 2009
  end-page: 321
  ident: bib15
  article-title: IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice
  publication-title: Clin Immunol
– volume: 279
  start-page: H2196
  year: 2000
  end-page: H2201
  ident: bib36
  article-title: Leukocyte and endothelial cell adhesion molecules in a chronic murine model of myocardial reperfusion injury
  publication-title: Am J Physiol Heart Circ Physiol
– volume: 49
  start-page: 185
  year: 2010
  end-page: 193
  ident: bib8
  article-title: The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice
  publication-title: Cytokine
– volume: 45
  start-page: 661
  year: 2000
  end-page: 670
  ident: bib25
  article-title: Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart
  publication-title: Cardiovasc Res
– volume: 77
  start-page: 5059
  year: 2009
  end-page: 5070
  ident: bib34
  article-title: Critical role of the interleukin-17/interleukin-17 receptor axis in regulating host susceptibility to respiratory infection with Chlamydia species
  publication-title: Infect Immun
– volume: 34
  start-page: 229
  year: 2006
  end-page: 242
  ident: bib5
  article-title: IL-17A-producing neutrophil-regulatory Tn lymphocytes
  publication-title: Immunol Res
– volume: 120
  start-page: 331
  year: 2010
  end-page: 342
  ident: bib14
  article-title: IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury
  publication-title: J Clin Invest
– volume: 20
  start-page: 445
  year: 2006
  end-page: 462
  ident: bib16
  article-title: The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy
  publication-title: Cardiovasc Drugs Ther
– volume: 61
  start-page: 481
  year: 2004
  end-page: 497
  ident: bib20
  article-title: Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury
  publication-title: Cardiovasc Res
– volume: 303
  start-page: 1152
  year: 2003
  ident: 10.1016/j.jacc.2011.10.863_bib17
  article-title: TNF-alpha and H2O2 induce IL-18 and IL-18R beta expression in cardiomyocytes via NF-kappa B activation
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/S0006-291X(03)00496-0
– volume: 76
  start-page: 135
  year: 2004
  ident: 10.1016/j.jacc.2011.10.863_bib33
  article-title: Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.0204065
– volume: 102
  start-page: 240
  year: 2009
  ident: 10.1016/j.jacc.2011.10.863_bib21
  article-title: The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury
  publication-title: Thromb Haemost
  doi: 10.1160/TH08-12-0837
– volume: 11
  start-page: 625
  year: 2009
  ident: 10.1016/j.jacc.2011.10.863_bib6
  article-title: IL-17 and Th17 cells in human inflammatory diseases
  publication-title: Microbes Infect
  doi: 10.1016/j.micinf.2009.04.003
– volume: 453
  start-page: 1051
  year: 2008
  ident: 10.1016/j.jacc.2011.10.863_bib18
  article-title: Induction and effector functions of T(H)17 cells
  publication-title: Nature
  doi: 10.1038/nature07036
– volume: 184
  start-page: 4880
  year: 2010
  ident: 10.1016/j.jacc.2011.10.863_bib27
  article-title: IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0901767
– volume: 180
  start-page: 655
  year: 2008
  ident: 10.1016/j.jacc.2011.10.863_bib32
  article-title: IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood
  publication-title: J Immunol
  doi: 10.4049/jimmunol.180.1.655
– volume: 207
  start-page: 1293
  year: 2010
  ident: 10.1016/j.jacc.2011.10.863_bib26
  article-title: Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A
  publication-title: J Exp Med
  doi: 10.1084/jem.20092054
– volume: 103
  start-page: 2296
  year: 2001
  ident: 10.1016/j.jacc.2011.10.863_bib35
  article-title: Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine
  publication-title: Circulation
  doi: 10.1161/01.CIR.103.18.2296
– volume: 55
  start-page: 500
  year: 2010
  ident: 10.1016/j.jacc.2011.10.863_bib10
  article-title: Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.109.145094
– volume: 357
  start-page: 1121
  year: 2007
  ident: 10.1016/j.jacc.2011.10.863_bib2
  article-title: Myocardial reperfusion injury
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra071667
– volume: 183
  start-page: 8167
  year: 2009
  ident: 10.1016/j.jacc.2011.10.863_bib9
  article-title: Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0901126
– volume: 49
  start-page: 185
  year: 2010
  ident: 10.1016/j.jacc.2011.10.863_bib8
  article-title: The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2009.09.007
– volume: 31
  start-page: 181
  year: 2009
  ident: 10.1016/j.jacc.2011.10.863_bib24
  article-title: Gammadelta T cell receptors without a job
  publication-title: Immunity
  doi: 10.1016/j.immuni.2009.08.004
– volume: 279
  start-page: H2196
  year: 2000
  ident: 10.1016/j.jacc.2011.10.863_bib36
  article-title: Leukocyte and endothelial cell adhesion molecules in a chronic murine model of myocardial reperfusion injury
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.2000.279.5.H2196
– volume: 130
  start-page: 313
  year: 2009
  ident: 10.1016/j.jacc.2011.10.863_bib15
  article-title: IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2008.09.019
– volume: 97
  start-page: 738
  year: 2007
  ident: 10.1016/j.jacc.2011.10.863_bib31
  article-title: Chemokines in ischemia and reperfusion
  publication-title: Thromb Haemost
  doi: 10.1160/TH07-01-0022
– volume: 185
  start-page: 4004
  year: 2010
  ident: 10.1016/j.jacc.2011.10.863_bib11
  article-title: Th17 cells contribute to viral replication in coxsackievirus B3-induced acute viral myocarditis
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1001718
– volume: 127
  start-page: 89
  year: 2008
  ident: 10.1016/j.jacc.2011.10.863_bib23
  article-title: The Th17/Treg imbalance in patients with acute coronary syndrome
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2008.01.009
– volume: 99
  start-page: 12825
  year: 2002
  ident: 10.1016/j.jacc.2011.10.863_bib30
  article-title: Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.202474099
– volume: 21
  start-page: 467
  year: 2004
  ident: 10.1016/j.jacc.2011.10.863_bib3
  article-title: Interleukin-17 family members and inflammation
  publication-title: Immunity
  doi: 10.1016/j.immuni.2004.08.018
– volume: 20
  start-page: 353
  year: 2008
  ident: 10.1016/j.jacc.2011.10.863_bib4
  article-title: gammadelta T cells: an important source of IL-17
  publication-title: Curr Opin Immunol
  doi: 10.1016/j.coi.2008.03.006
– volume: 120
  start-page: 331
  year: 2010
  ident: 10.1016/j.jacc.2011.10.863_bib14
  article-title: IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury
  publication-title: J Clin Invest
  doi: 10.1172/JCI38702
– volume: 34
  start-page: 229
  year: 2006
  ident: 10.1016/j.jacc.2011.10.863_bib5
  article-title: IL-17A-producing neutrophil-regulatory Tn lymphocytes
  publication-title: Immunol Res
  doi: 10.1385/IR:34:3:229
– volume: 75
  start-page: 426
  year: 1994
  ident: 10.1016/j.jacc.2011.10.863_bib29
  article-title: Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes
  publication-title: Circ Res
  doi: 10.1161/01.RES.75.3.426
– volume: 184
  start-page: 4531
  year: 2010
  ident: 10.1016/j.jacc.2011.10.863_bib37
  article-title: IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0903162
– volume: 129
  start-page: 311
  year: 2010
  ident: 10.1016/j.jacc.2011.10.863_bib19
  article-title: Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
  publication-title: Immunology
  doi: 10.1111/j.1365-2567.2009.03240.x
– volume: 355
  start-page: 2475
  year: 2006
  ident: 10.1016/j.jacc.2011.10.863_bib1
  article-title: Myocardial infarction and the open-artery hypothesis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMe068251
– volume: 61
  start-page: 481
  year: 2004
  ident: 10.1016/j.jacc.2011.10.863_bib20
  article-title: Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury
  publication-title: Cardiovasc Res
  doi: 10.1016/j.cardiores.2003.10.011
– volume: 106
  start-page: 1646
  year: 2010
  ident: 10.1016/j.jacc.2011.10.863_bib12
  article-title: Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.109.213157
– volume: 45
  start-page: 661
  year: 2000
  ident: 10.1016/j.jacc.2011.10.863_bib25
  article-title: Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart
  publication-title: Cardiovasc Res
  doi: 10.1016/S0008-6363(99)00393-4
– volume: 23
  start-page: 1
  year: 2009
  ident: 10.1016/j.jacc.2011.10.863_bib22
  article-title: Lymphocytes and ischemia-reperfusion injury
  publication-title: Transplant Rev (Orlando)
  doi: 10.1016/j.trre.2008.08.003
– volume: 215
  start-page: 471
  year: 2011
  ident: 10.1016/j.jacc.2011.10.863_bib7
  article-title: Inhibition of IL-17A in atherosclerosis
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2010.12.034
– volume: 15
  start-page: 946
  year: 2009
  ident: 10.1016/j.jacc.2011.10.863_bib13
  article-title: Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury
  publication-title: Nat Med
  doi: 10.1038/nm.1999
– volume: 20
  start-page: 445
  year: 2006
  ident: 10.1016/j.jacc.2011.10.863_bib16
  article-title: The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy
  publication-title: Cardiovasc Drugs Ther
  doi: 10.1007/s10557-006-0583-7
– volume: 77
  start-page: 388
  year: 2005
  ident: 10.1016/j.jacc.2011.10.863_bib28
  article-title: Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.0904490
– volume: 77
  start-page: 5059
  year: 2009
  ident: 10.1016/j.jacc.2011.10.863_bib34
  article-title: Critical role of the interleukin-17/interleukin-17 receptor axis in regulating host susceptibility to respiratory infection with Chlamydia species
  publication-title: Infect Immun
  doi: 10.1128/IAI.00403-09
SSID ssj0006819
Score 2.51177
Snippet This study tested whether interleukin (IL)-17A is involved in the pathogenesis of mouse myocardial ischemia/reperfusion (I/R) injury and investigated the...
ObjectivesThis study tested whether interleukin (IL)-17A is involved in the pathogenesis of mouse myocardial ischemia/reperfusion (I/R) injury and investigated...
Objectives This study tested whether interleukin (IL)-17A is involved in the pathogenesis of mouse myocardial ischemia/reperfusion (I/R) injury and...
OBJECTIVES: This study tested whether interleukin (IL)-17A is involved in the pathogenesis of mouse myocardial ischemia/reperfusion (I/R) injury and...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 420
SubjectTerms Animals
Apoptosis
Biological and medical sciences
Cardiology
Cardiology. Vascular system
Cardiomyocytes
Cardiovascular
Cell Adhesion
Chemokines
Chemokines, CXC - metabolism
Coronary heart disease
Coronary vessels
E-Selectin - metabolism
Endothelial Cells - physiology
Endothelium
Gene Knockout Techniques
Heart
Heart attacks
Immune system
inflammation
Intercellular Adhesion Molecule-1 - metabolism
interleukin-17
Interleukin-17 - physiology
Ischemia
ischemia/reperfusion
Lymphocytes
Medical sciences
Mice
Mice, Inbred C57BL
Migration
Myocardial Reperfusion Injury - immunology
Myocardial Reperfusion Injury - metabolism
Myocarditis. Cardiomyopathies
Myocytes, Cardiac - physiology
Neutrophil Infiltration
Oxidative Stress
Proteins
Rodents
T-Lymphocyte Subsets - metabolism
γδT cell
Title Interleukin-17A Contributes to Myocardial Ischemia/Reperfusion Injury by Regulating Cardiomyocyte Apoptosis and Neutrophil Infiltration
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0735109711048182
https://www.clinicalkey.es/playcontent/1-s2.0-S0735109711048182
https://dx.doi.org/10.1016/j.jacc.2011.10.863
https://www.ncbi.nlm.nih.gov/pubmed/22261166
https://www.proquest.com/docview/1645043361
https://www.proquest.com/docview/1008826820
https://www.proquest.com/docview/917157711
Volume 59
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LatwwUIQcSqGUpE83aVCht-KuZcmyddwuDdlCcmgb2JuQZZl6u7HN2j7sJdf8dka2vEtoN4VeDJY1ljUzmoc1mkHoI2WUplqFfg4U9hkYpL6wzkqiQDkHKrQ7Qzba4opfXLNvi2hxgGbjWRgbVulk_yDTe2ntWiYOm5O6KCY_gDkju38KCoyB2rFymLHYcvnn212YB0_64h62s297u4MzQ4zXUmk9pPGEtoTTfcrpWa0aQFk-1LrYb4z2Sun8CD131iSeDh98jA5M-QI9uXT75S_RXf_Db2W630Xpk3iKbTKqvsSVaXBb4csNqDLLIis8BzfX3BRqAia5Weed_YuG5-UScI7TDf4-1KwHRYdnfQjrDYBuWoOndVW3VVM0WJUZvjJdu67qXwW8sMyLlUvK-wpdn3_9ObvwXekFX3OStH5O04izWAPdaBoYBesWPMEUHFrBWQZuJCVMs5RFOs6V0anIlSbCZAks9ywTAX2NDsuqNG8R5lHEUyVCpUwEMEQkXORM0CQIFRGKeYiMOJfa5SW35TFWcgxAW0pLJ2npZNuATh76tIWph6wcj_amIynleN4UJKQEpfEoVPw3KNO4Rd5IIptQBvIPRvRQtIV8wMv_HPHsAZ9tpwZmKQfJCqg6HRlP7r6Csz4LHSce-rB9DELC7vyo0lRdYxNTgyfFwdrzEN7TB_x2EsUwCQ-9GXh6Nz7Y6IRw_u4_J3aCnsKdDQHyQ3aKDtt1Z96DLdemZ_1ihet88eUeBwtGcA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkGASQnwTGMNI8IRCY8dx4gceqsHUsrUPsEl7M07qjHRdEjWpUF945Q_iH-ScOK0m6JCQ9urk4o87_-4uPt8h9Npnvh8niropcNhlYJC6wjgrkQLl7ClqToZMtMWYD07Yp9PgdAv96u7CmLBKi_0tpjdobVt6djV7ZZb1voBwBub8FBQYA7VDbWTloV5-B7-tej_8AEx-Q-nBx-P9gWtLC7gJJ1Htpn4ccBYmMC4_9rQyReqZF4PDJjibgJvkE5awmAVJmCqdxCJVCRF6EoE4TybC8-G7N9BNBnBhyia8-7GOK-FRU03EjM41w7M3ddqgsqlKkjZvKLRF3N-kDe-UqgIepW1xjc3Wb6MFD-6hu9Z8xf12he6jLZ0_QLdG9oD-IfrZ_GGc6cV5lrsk7GOT_aqpqaUrXBd4tATdaWRyhofgV-uLTPXAB9DzdGF-2-FhPgUm43iJP-uzprJYfob3m5jZCyBd1hr3y6KsiyqrsMoneKwX9bwov2XwwTzNZjYL8CN0ci0MeYy28yLXTxHmQcBjJahSOgAaIiIuUib8yKOKCMUcRLo1l4lNhG7qccxkF_E2lYZP0vDJtAGfHPR2RVO2aUCufNvvWCm7C64AyRK01JVU4d-odGVRpZJEVlR68g_Jd1Cwory0ef7Z494lOVtNDexgDlAOS7XbCZ5cj4KzJu0dJw56tXoMqGSOmlSui0VlMmGD68bBvHQQ3vCOICEJQpiEg560Mr3uH5wCQjh_9p8Te4luD45HR_JoOD58jnZok4adupTtou16vtAvwJCs471m42L09bqR4jfMR4IY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interleukin-17A+Contributes+to+Myocardial+Ischemia%2FReperfusion+Injury+by+Regulating+Cardiomyocyte+Apoptosis+and+Neutrophil+Infiltration&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Liao%2C+Yu-Hua&rft.au=Xia%2C+Ni&rft.au=Zhou%2C+Su-Feng&rft.au=Tang%2C+Ting-Ting&rft.date=2012-01-24&rft.pub=Elsevier+Inc&rft.issn=0735-1097&rft.eissn=1558-3597&rft.volume=59&rft.issue=4&rft.spage=420&rft.epage=429&rft_id=info:doi/10.1016%2Fj.jacc.2011.10.863&rft.externalDocID=S0735109711048182
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07351097%2FS0735109711X00529%2Fcov150h.gif